The meal hydrolysate group had significantly higher levels of anti‐inflammatory IL‐10 protein expression, slightly decreased pro‐inflammatory TNF‐α protein expression, and significantly reduced TNF‐α gene expression compared to the control group, suggesting that the meal‐hydrolysate treatment inhibited acute inflammation and enhanced colon recovery from colitis.[150] Microalgal compounds with therapeutic potential for IBD include tocopherols from Porphydium sp. The gene discussed is TNF; the disease is inflammatory bowel disease.